Cargando…

A short-duration dark adaptation protocol for assessment of age-related maculopathy

Dark adaptometry may be a useful diagnostic test and clinical trial endpoint for age-related maculopathy (ARM) because impaired night vision is a hallmark of early ARM. A novel dark adaptometer, the AdaptDx, was evaluated for the detection of ARM. The AdaptDx incorporates a 20-minute protocol optimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Gregory R., Edwards, John G.
Formato: Texto
Lenguaje:English
Publicado: Humana Press Inc 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802416/
https://www.ncbi.nlm.nih.gov/pubmed/20072631
http://dx.doi.org/10.1007/s12177-008-9002-6
_version_ 1782175996800139264
author Jackson, Gregory R.
Edwards, John G.
author_facet Jackson, Gregory R.
Edwards, John G.
author_sort Jackson, Gregory R.
collection PubMed
description Dark adaptometry may be a useful diagnostic test and clinical trial endpoint for age-related maculopathy (ARM) because impaired night vision is a hallmark of early ARM. A novel dark adaptometer, the AdaptDx, was evaluated for the detection of ARM. The AdaptDx incorporates a 20-minute protocol optimized for the detection of ARM. ARM patients (N = 17) exhibited substantial dark adaptation impairment compared with normal adults (N = 17). The diagnostic sensitivity was 88% and the specificity was 100%. The diagnostic test characteristics of the AdaptDx are similar to previously reported studies using 60- to 120-minute protocols.
format Text
id pubmed-2802416
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Humana Press Inc
record_format MEDLINE/PubMed
spelling pubmed-28024162010-01-12 A short-duration dark adaptation protocol for assessment of age-related maculopathy Jackson, Gregory R. Edwards, John G. J Ocul Biol Dis Infor Article Dark adaptometry may be a useful diagnostic test and clinical trial endpoint for age-related maculopathy (ARM) because impaired night vision is a hallmark of early ARM. A novel dark adaptometer, the AdaptDx, was evaluated for the detection of ARM. The AdaptDx incorporates a 20-minute protocol optimized for the detection of ARM. ARM patients (N = 17) exhibited substantial dark adaptation impairment compared with normal adults (N = 17). The diagnostic sensitivity was 88% and the specificity was 100%. The diagnostic test characteristics of the AdaptDx are similar to previously reported studies using 60- to 120-minute protocols. Humana Press Inc 2008-05-06 2008-03 /pmc/articles/PMC2802416/ /pubmed/20072631 http://dx.doi.org/10.1007/s12177-008-9002-6 Text en © Humana Press 2008
spellingShingle Article
Jackson, Gregory R.
Edwards, John G.
A short-duration dark adaptation protocol for assessment of age-related maculopathy
title A short-duration dark adaptation protocol for assessment of age-related maculopathy
title_full A short-duration dark adaptation protocol for assessment of age-related maculopathy
title_fullStr A short-duration dark adaptation protocol for assessment of age-related maculopathy
title_full_unstemmed A short-duration dark adaptation protocol for assessment of age-related maculopathy
title_short A short-duration dark adaptation protocol for assessment of age-related maculopathy
title_sort short-duration dark adaptation protocol for assessment of age-related maculopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802416/
https://www.ncbi.nlm.nih.gov/pubmed/20072631
http://dx.doi.org/10.1007/s12177-008-9002-6
work_keys_str_mv AT jacksongregoryr ashortdurationdarkadaptationprotocolforassessmentofagerelatedmaculopathy
AT edwardsjohng ashortdurationdarkadaptationprotocolforassessmentofagerelatedmaculopathy
AT jacksongregoryr shortdurationdarkadaptationprotocolforassessmentofagerelatedmaculopathy
AT edwardsjohng shortdurationdarkadaptationprotocolforassessmentofagerelatedmaculopathy